NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
The summary for the NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional): Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (pre-clinical or clinical).
Federal Grant Title: | NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Education, Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-25-139 |
Type of Funding: | Grant |
CFDA Numbers: | 93.393, 93.394, 93.395, 93.396, 93.399 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | July 1st, 2025 |
Original Application Deadline: | July 1st, 2025 |
Posted Date: | November 4th, 2024 |
Creation Date: | November 4th, 2024 |
Archive Date: | August 6th, 2025 |
Total Program Funding: | $200,000 |
Maximum Federal Grant Award: | $275,000 |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | November 4th, 2024 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/pa-files/PAR-25-139.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologie...
- • Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detec...
- • Co-infection and Cancer (R01 Clinical Trial Not Allowed)
- • Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinica...
- • Biology of Bladder Cancer (R21 Clinical Trial Optional)
- • Pilot Studies in Pancreatic Cancer
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- More Grants from the National Institutes of Health
- • Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- • Alcohol Health Services Research (R01 Clinical Trial Optional)
- • Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- • Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Re...
- • Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the...